• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Chris Newmarker

Freudenberg Medical completes extractables testing for its PharmaFocus Premium tubing

April 28, 2020 By Chris Newmarker

Freudenberg Medical PharmaFocus Premium silicone tubing

Freudenberg Medical (Carpinteria, Calif.) today touted extractables testing performed on its PharmaFocus Premium silicone tubing used in biopharma fluid processing and single-use applications. Eurofins Lancaster Laboratories conducted the independent extractables testing for Freudenberg Medical, drawing on BPOG and USP 665 protocols. “We understand that identifying extractable and leachable substances is extremely important for our biopharma […]

Filed Under: Materials Testing, Pharmaceuticals Tagged With: Freudenberg Medical

This coin-sized insulin patch could improve diabetes treatment

March 6, 2020 By Chris Newmarker

adhesive microneedle coin-sized insulin patch UCLA diabetes

Could treating diabetes someday be as simple as slapping on a patch? A UCLA-led research team thinks so, and it’s seeking FDA permission to prove it. A research team led by UCLA bioengineering professor Zhen Gu claims to have overcome some of the technological hurdles around creating a patch that releases insulin based on the […]

Filed Under: Diabetes, Drug-Device Combinations Tagged With: insulin, UCLA, Zenomics

Insulet’s Omnipod Dash Personal Diabetes Managers have a glitch

February 13, 2020 By Chris Newmarker

Insulet Ominipod Dash Personal Diabetes Managers

Insulet (NSDQ:PODD) is issuing a voluntary medical device correction for all of the smartphone-like Personal Diabetes Managers that came with its next-gen Omnipod Dash insulin management system, the company announced today. During its ongoing quality management process, Insulet officials discovered that the PDMs on rare occasions will suggest an inaccurate bolus amount based on a blood […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, mHealth (Mobile Health), Recalls Tagged With: Insulet, insulin

FDA says Medtronic MiniMed insulin pump recall is serious

February 12, 2020 By Chris Newmarker

Medtronic Minimed 630g

The U.S. FDA has designated a recall of hundreds of thousands of Medtronic Minimed insulin pumps as Class I — the most serious type of recall. Medtronic (NYSE:MDT) first warned of safety problems with the pumps in November. The recall involves 322,005 pumps — MiniMed 630G (model MMT-1715) and MiniMed 670G (model MMT-1780) — in the […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Recalls Tagged With: insulin, Medtronic

Abbott boosts support for Bigfoot Biomedical and its diabetes treatment tech

January 13, 2020 By Chris Newmarker

Bigfoot Biomedical Abbott Bigfoot Unity diabetes management program

Diabetes treatment tech company Bigfoot Biomedical has raised another $45 million in the initial tranche of a Series C equity financing, with collaborator Abbott (NYSE:ABT)  as the lead investor. “We are excited to announce Abbott’s deepening support of Bigfoot Biomedical with this Series C financing,” Bigfoot Biomedical CEO Jeffrey Brewer said in a news release today.  […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: abbott, Abbott Laboratories, artificial pancreas, Bigfoot Biomedical, insulin

Phillips-Medisize expands Denmark site

January 8, 2020 By Chris Newmarker

Phillips-Medisize, a Molex company,  announced today that it has expanded its Global Innovation and Development site in Struer, Denmark. The Hudson, Wis.–based company — a contract manufacturing giant in the drug delivery device space — plans to open a dedicated Manufacturing Development and Clinical build unit in Stuer by the second quarter of 2020. Get […]

Filed Under: Contract Services, Drug-Device Combinations, Featured Tagged With: Phillips-Medisize

Medinol stent performs just as well as Medtronic Resolute, study says

January 6, 2020 By Chris Newmarker

Medinol EluNIR drug-eluting stent

The EluNIR drug-eluting stent made by Medinol performed just as well as the Resolute Integrity or Resolute Onyx stents from Medtronic (NYSE:MDT), according to new clinical study results from an international team of researchers. The randomized clinical trial — conducted by researchers from the U.S., Israel, Canada and the Netherlands — involved 2,221 people and compared […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Stents Tagged With: Cardinal Health, medinol, Medtronic

Delcath Systems announces reverse stock split

December 24, 2019 By Chris Newmarker

delcath-systems

A reverse stock split went into effect today for Delcath Systems (OTC:DCTH) — developer of the Chemostat hepatic delivery system for treating cancer. The 1-for-700 reverse stock split is meant to reduce the number of common stock shares and shares reserved for issuance to 1.2 million, from a previous 1.4 billion. The authorized number of shares […]

Filed Under: Business/Financial News, Featured, Oncology, Wall Street Beat Tagged With: Delcath Systems Inc.

W.L. Gore officials think they can spur insulin delivery system innovation

December 6, 2019 By Chris Newmarker

W.L. Gore PhysioLogic Devices

W.L. Gore announced this week that it is investing in PhysioLogic Devices, a startup developing an implantable intraperitoneal insulin delivery system. The size of the investment was not disclosed. But it was part of Gore’s Micro-Equity Investment (MEI) program, which provides investments of up to $500,000. W.L. Gore officials think the company’s more than 60 years […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: PhysioLogic Devices, W.L. Gore

OncoSec $30m fundraise threatened by spat

December 2, 2019 By Chris Newmarker

OncoSec

OncoSec Medical (NSDQ:ONCS) is embroiled in a lawsuit and proxy war over a $30 million money-raise as it seeks to continue development of its cancer treatment technology. The company — headquartered in San Diego and Pennington, N.J. — sent a letter to shareholders today in which it countered what it described as false and misleading statements […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Legal News, Oncology Tagged With: Alpha Holdings, Cancer, China Grand Pharmaceutical and Healthcare Holdings, OncoSec Medical, Sirtex Medical Holdings

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 8
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS